In HTN , CAD, HF, AF ,Angina, Post MI and HTN with CKD
DEVMET- 25 /50
Metoprolol Tartrate 25/50 mg Extended release

As per ESC 2024
GDMT endorses beta blockers as the choice of therapy for an additional 19 Indicators

As per  AHA 2023
Beta blockers like Metoprolol improve BP and HR in CAD patients

As per ISH 2024
Long term use of Beta blocker in Pre and Post MI in patients with CCD and reduced LVEF

  • Reduces sudden cardiac death by 38% (RRR)
  • 63.1% Clinicians refers Metoprolol in young Hypertensives.
Scroll to Top